Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2022-05-05
Summary
To prospectively collect whole blood specimens and clinical data from pregnant women scheduled for an invasive prenatal diagnostic procedure ("invasive procedure"). Specimens will be used for future testing with an investigational NIPT.
Conditions
- Pregnancy Related
Sponsors & Collaborators
-
Illumina, Inc.
lead INDUSTRY
Principal Investigators
-
Kathryn Waldrep, MD · Medical City Dallas Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-13
- Primary Completion
- 2019-08-30
- Completion
- 2019-12-31
Countries
- United States
- Australia
- Malaysia
- Poland
- Thailand
- Ukraine
Study Locations
More Related Trials
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
NCT06690099 ·Status: RECRUITING
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 ·Status: RECRUITING
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Cell-Based Noninvasive Prenatal Testing
NCT05245266 ·Status: UNKNOWN ·Phase: NA
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Development of a Fetal Sex Assay From Maternal Whole Blood
NCT00970047 ·Status: COMPLETED
-
Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987 ·Status: COMPLETED
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
NCT05453474 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Late Pregnancy Sample Collection Study
NCT04010682 ·Status: COMPLETED
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Noninvasive Fetal RHD Genotyping Test
NCT01054716 ·Status: COMPLETED
-
Evaluation of Coagulation Status of Pregnant Women in the Peripartum Period Using the Device Clotpro®
NCT05935137 ·Status: COMPLETED
-
Non Invasive Prenatal Test of Rare Genetic Diseases: Application to Rare Intellectual Disabilities
NCT03688594 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
NCT00700219 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED